smokers (87.5% vs 97.2%), and higher SPARCC SI joints score (5.32 vs 3.17). Higher BASDAI was observed among female sex. BASMI varies little but the group with highest BASMI (3.60 vs 3.62) also had highest mSASSS (20.33 vs 20.33). Conclusion: Our data showed that male smokers with HLA-B27 positivity and SI joints inflammation have more radiological damage and higher prevalence of AS, consistent with known poor prognosis factors.
Introduction
Axial spondyloarthritis (AxSpA) represents a spectrum of diseases where back pain is the core symptom. The disease can cause axial-joint inflammation, erosion, and new bone formation, leading to functional impairment. Traditional assessment tools include Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) (1) and Bath Ankylosing Spondylitis Functional Index (BASFI) (2), which are designed to assess spondyloarthritis (SpA) disease activity and daily function, respectively. Although the tools are well validated, the relationships between disease activity, functional status, axial-joint inflammation, and degree of syndesmophytes formation are more complicated. Studies showed that disease activity might not correlate with axial-joint inflammation (3, 4) and functional impairment could be caused by both axial-joint inflammation and structural damage of the spine (5).
In addition, rheumatologists are trying to find the prognostic factors for syndesmophytes formation. So far, the identified potential risk factors include male sex (6), human leukocyte antigen (HLA) B27 positivity (7), smoker (8), and an initially raised C-reactive protein (CRP) (9) . As some of the risk factors are potentially modifiable, it would be of interest to know if they will also apply in our local population. By categorizing a group of patients with AxSpA, we aimed to describe the clinical characteristics and their relationships with disease activity, functional status, and syndesmophytes formation.
Methods
This is a cross-sectional analysis of a cohort of patients with AxSpA recruited consecutively from two rheumatology centers in Hong Kong (Queen Mary Hospital and Pamela Youde Nethersole Eastern Hospital) from March 2014 to August 2016. Our study design is a follow-up cohort of at least one year to determine the changes in magnetic resonance imaging (MRI) features (short tau inversion recovery [STIR] and diffusion-weighted imaging) in patients with AxSpA. Data descriptors in the manuscript consisted only of the initial time point and STIR images only. Written consent was obtained from all study patients. Inclusion criteria included (i) rheumatologist-diagnosed AxSpA fulfilling Assessment of SpondyloArthritis International Society (ASAS) classification criteria, (ii) age greater than 18 years, (iii) current back pain, (iv) ability to give written consent, and (v) biologics naïve. Exclusion criteria included (i) pregnancy and (ii) inability to undergo MRI examination.
Clinical and blood parameters were collected. These included age, sex, smoking and drinking history, duration of back pain, location and characteristic of back pain, extraspinal features, associated medical history, HLA-B27 status, CRP, and erythrocyte sedimentation rate (ESR). Patients completed a set of self-assessment questionnaires-BASDAI, BASFI, and Bath Ankylosing Spondylitis Global Index (BASGI) (10)-to calculate the Ankylosing Spondylitis Disease Activity Score (ASDAS) (11) . Spinal mobility was measured according to the Bath Ankylosing Spondylitis Metrology Index (BASMI) (12) . Radiographs of cervical and lumbosacral spine were used to determine the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) (13) and radiological sacroiliitis based on the Modified New York (MNY) criteria (14) : grade 0, normal; 1, doubtful; 2, obvious; 3, fusion. Bilateral sacroiliitis grade 2 or above or unilateral sacroiliitis grade 3 or above was defined as radiological AS. All patients had a whole spine and sacroiliac (SI) joints MRI. Details of the MRI sequence and technical parameters were described in our previous publication (15) . STIR sequence of the SI joints was graded according to the spondyloarthritis research consortium of Canada (SPARCC) MRI inflammation scoring method (16) by two independent scorers (scorer one CHY being a rheumatologist and scorer two CWC a rheumatology trainee). Positive MRI SI joints inflammation was defined as SPARCC SI joints score ≥2.
Statistical analyses
Two-step cluster analysis was performed. Cluster variables were selected based on the data collected, which include male sex, HLA-B27 status, smoker, drinker, age, and SPARCC score. BASDAI, BASFI, BASMI, mSASSS, and radiological AS were used as the outputs. Mean CRP and ESR of each clusters were calculated. Data was described by mean, median, and frequency of occurrences using percentages. Interobserver correlation of SPARCC SI joints scores was checked using correlation coefficient. All statistics were performed using the statistical product and service solutions (SPSS) package 21.0. 
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Results
One hundred and sixty three patients were recruited. Baseline characteristics were shown in Table 1 . Our cohort was characterized by long disease duration, high disease activity, moderate functional impairment, significant radiological damage, and radiological AS. Interobserver correlation of SPARCC SI joints scores was 92.3% (p < 0.001).
Two cluster analyses were performed using SPACC SI joints scores from the two independent scorers.
The cohort was clustered into four groups. All groups had similar BASMI.
Cluster 1: High disease activity (BASDAI = 4.88), preserved functional status (BASFI = 2.88), high radiological damages (mSASSS = 20.33), BASMI = 3.60, radiological AS in 85% of population. The cluster consisted of 40(30.1%) patients. HLA-B27 positivity was radiological damages (mSASSS = 7.75), BASMI 3.38, radiological AS in 66% of population. The cluster consisted of 38(28.6%) patients. All patients were found to have HLA-B27 positivity. All of them were male. All of population were smokers and none of them were drinker. Average age was 38.6 years, and average SPARCC SI joints score was 2.82. Mean CRP was 0.99 mg/dl, and mean ESR found in 70.0% of the population. Most of them were male (75.0%). There were 87.5% smokers and 40% drinker. Average age was 42.8 year, and average SPARCC SI joints score was 5.32. Mean CRP was 1.10 mg/dl, and mean ESR was 34.92 mm/h.
Cluster 2: Low disease activity (BASDAI = 3.74), preserved functional impairment (BASFI = 2.68), some was 25.39mm/h. Cluster 3: High disease activity (BASDAI = 4.97), worse functional status (BASFI = 3.40), minimal radiological damages (mSASSS = 2.12), BASMI = 3.38, radiological AS in 56% of population. The cluster consisted of 34(25.6%) patients. All patients were found to have HLA-B27 positivity. All of them were female. None of the population were smoker or drinker. Average age was 44.9 years, and average SPARCC SI joints score was 1.74. Mean CRP was 1.11 mg/dl, and mean ESR was 38.26 mm/h.
Cluster 4: Highest BASDAI (BASDAI = 5.37), preserved functional status (BASFI = 2.90), some radiological damages (mSASSS = 5.67), BASMI = 3.44, radiological AS in 57% of population. The cluster consisted of 21(15.8%) patients. All patients were HLA-B27 negative. Female patients consisted of 61.9% of the population. There was no smoker or drinker. Average age was 46.1 years, and average SPARCC SI joints score was 3.00. Mean CRP was 1.56 mg/dl, and mean ESR was 39.52 mm/h.
Cluster 1. Low disease activity (BASDAI = 3.81), preserved functional status (BASFI = 2.65), some radiological damages (mSASSS = 7.75), BASMI = 3.40, radiological AS in 68% of population. The cluster consisted of 41(30.8%) patients. All patients were HLA-B27 positive. The population had 97.6% male. There was no smoker and 7.3% of them were drinkers. Average age was 37.8 years, and average SPARCC SI joints score was 5. 10 Cluster 4. Highest disease activity (BASDAI = 5.61), moderate functional impairment (BASFI = 3.23), some radiological damages (mSASSS = 5.67), BASMI = 3.59, radiological AS in 57% of population. The cluster consisted of 21(15.8%) patients. All patients were HLA-B27 negative. Male patients consisted of 38.1% of population. None of them was smoker or drinker. Average age was 47.1 years, and average SPARCC SI joints score was 2.62. Mean CRP was 1.91 mg/dl, and mean ESR 43.48 mm/h. In a group of patients with long-standing SpA, we described the clinical characteristics in relation to disease activity, functional status, and radiological damages. The percentage of patients with positive MRI SI joints inflammation was similar to an international study (17) . Although MRI films were scored by two independent scorers, clinical features described were quite similar in the two models. BASDAI is a well-validated tool traditionally used by rheumatologists to assess and describe SpA disease activity. Despite its popularity, studies have shown that BASDAI may not correlate with MRI inflammation (3, 4). We also reported similar findings in our previous manuscript (15) . From our clustered models, BASDAI was not in phase with SPARCC SI joints score, further suggesting that BASDAI may not be a good marker for axial-joint inflammation. However, we did not obtain the SPARCC spine score. We may have potentially underestimated the overall axial-joint inflammation.
Our cluster models showed that the group of patients with high mSASSS were also the group with greatest percentage of radiological AS. The reason could be obvious as patients with spinal radiological damages are more likely to have damages at the SI joints. The group of patients with highest mSASSS were male smokers with HLA-B27 positivity and higher SPARCC SI joints score. The findings correlate with the poor prognostic factors that are previously documented (6-8). Nevertheless, we did not have the initial CRP values and could not assess for this risk factor in our cluster models.
We observed higher BASDAI scores in women. Similar findings have been shown in a previous study that reported women to have higher pain, AS quality of life, ASDAS-ESR, BASDAI item, ESR, patient's global and physician's global assessment (18) . The exact reason behind is not known. It is worth to note that women are at greater risk of developing chronic pain (19) (20) (21) . Whether this could affect the interpretation of BASDAI is unknown.
BASMI has been reported to be affected by both structural damage and spinal inflammation (22) . In patients with disease duration of greater than 3 years, BASMI is more influenced by spinal damage (22) . Our study population was characterized by long disease durations. Although there was little variation of BASMI in our clusters, our results were compatible with previous study. The groups with highest mSASSS also had highest BASMI.
Finally, in our models, BASFI appears to be independent of BASDAI, mSASSS, and BASMI. It appears to us that the functional score is more complex and could have involved different factors. The Outcome in Ankylosing Spondylitis International Study showed BASFI is independently caused by patient reported disease activity and the level of structural damage of the lumbar and cervical spine (5).The complex relations with different factors was the likely cause of variation in BASFI. Our study is merely descriptive and, therefore, would not be able to draw any definitive conclusion. The cross-sectional design and small sample size are also the limitations of our study. By describing different characteristics of patients with SpA in relations to disease activity, functional status, and radiological damages, we hope to provide a clearer picture for rheumatologists to understand and interpret different clinical parameters and to provide management to patients accordingly.
